https://www.live-feeds.com/feed/over-15m-people-take-glp-1-drugs-in-america-and-54-agree-on-same-issueContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/over-15m-people-take-glp-1-drugs-in-america-and-54-agree-on-same-issuehttps://www.live-feeds.com/feed/over-15m-people-take-glp-1-drugs-in-america-and-54-agree-on-same-issue#u129147Sat, 17 Oct 2026 20:11:21 +0000More than 15 million people in the United States now use GLP-1 medications. These drugs are altering consumer eating habits and reshaping the food industry, particularly for snack makers. While they have reached widespread popularity, researchers are still investigating potential side effects involving vision, nails, and hair. The market for these medications is expanding rapidly, generating 79 billion dollars in sales in 2025 with projections reaching 190 billion dollars by 2035. Some insurance payers have responded to the surge by introducing coverage limits to control costs.Why it mattersGL